Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Secretory phospholipase A2 group IIA (sPLA2-IIA) is a secreted enzyme that hydrolyzes phospholipids, playing roles in inflammation, host defense, and eicosanoid signaling. It is implicated in various diseases including cardiovascular disease, inflammatory conditions, and cancer. Varespladib is an example of an inhibitor, but clinical trials have shown limited therapeutic benefits.
Inhibition of sPLA2-IIA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Secretory phospholipase A2 group IIA (sPLA2-IIA).